Orthocell Ltd has released a press release.
Orthocell Receives CE Mark for CelGro
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Orthocell
- Orthocell receives R&D tax incentive refund
- Orthocell Granted CelGro Patent Protection in Canada
- Notice of Annual General Meeting/Proxy Form
- Surgical Specialties Appointed as Exclusive Distributor
- Celgro Positive Safety and Performance in Human Hip Study
Later from Orthocell
- Orthocell Granted European Cartilage Regeneration Patent
- Orthocell Commences Treatment of Its 1,000th Patient
- Ortho-ATI Case Study Publication
- Orthocell Granted European Tendon Regeneration Patent
- 50% Patient Treatment Milestone in Human Nerve Trial
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell